NCT02354079View on ClinicalTrials.gov

HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism

NAActive, not recruitingINTERVENTIONAL
Enrollment

435

Participants

Timeline

Start Date

January 7, 2016

Primary Completion Date

January 7, 2022

Study Completion Date

January 7, 2032

Conditions
Hypobetalipoproteinemia
Interventions
GENETIC

hypobetalipoproteinemia genetic and genotypic screening

Trial Locations (1)

44093

CHU de Nantes, Nantes

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT02354079 - HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism | Biotech Hunter | Biotech Hunter